Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

Outcome of Hodgkin Lymphoma Patients Over Than 60 Years Treated by Chemotherapy and/or Radiotherapy: a Retrospective Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03535948

Acronym

HODGSA

Enrollment

Registered

2018-05-24

Start date

2018-05-15

Completion date

2019-12-31

Last updated

2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin Lymphoma, Adult

Brief summary

Outcome of Hodgkin lymphoma patients over than 60 years treated by chemotherapy and/or radiotherapy: retrospective analysis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients over than 60 years * Newly diagnosed Hodgkin lymphoma

Exclusion criteria

* Data not available

Design outcomes

Primary

Measure	Time frame	Description
Progression-free survival	Time between diagnosis and progression or death - up to 100 weeks	From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

Countries

France

Outcome results